Back Bay in Wall Street Journal Newsletter: Biotech M&A Deals Expected to Increase
Back Bay’s Managing Partner and CEO, Jonathan Gertler, was quoted in Wall Street Journal PRO Venture Capital article “Biotech M&A Deals Expected to Increase in 2017” by Brian Gormley posted on January 17.
"“We’re in a volatile time with regard to our industry,” said Jonathan Gertler, chief executive of Back Bay Life Science Advisors. “Anytime there’s volatility, there’s caution.”